Long-term benefit of atezolizumab plus chemotherapy in extensive stage small cell lung cancer (ES-SCLC): Exploratory analysis from the IMfirst study

被引：0

作者：

Garcia-Campelo, M. R. ^{[1
]}

Domine, M. ^{[2
]}

Carpeno, J. De Castro ^{[3
]}

Vega, A. L. Moreno ^{[4
]}

Aix, S. Ponce ^{[5
]}

Arriola, E. ^{[6
]}

Carcereny, E. ^{[7
]}

Majem, M. ^{[8
]}

Vence, G. Huidobro ^{[9
]}

Gonzalez, E. Esteban ^{[10
]}

Pradera, J. Fuentes ^{[11
]}

Granados, A. L. O. Ortega ^{[12
]}

Morales, M. Guillot ^{[13
]}

Sureda, B. Massuti ^{[14
]}

Barragan, P. Lianes ^{[15
]}

Calderon, R. Alonso ^{[16
]}

Fajardo, C. A. ^{[17
]}

Crama, L. ^{[17
]}

Laborda, N. Lerones ^{[18
]}

Dols, M. Cobo ^{[19
]}

机构：

[1] CHUAC Complexo Hosp Univ A Coruna, Dept Med Oncol, La Coruna, Spain

[2] Fdn Jimenez Diaz, Med Oncol, Madrid, Spain

[3] Hosp Univ La Paz, Med Oncol Dept, Madrid, Spain

[4] Hosp Univ Virgen Rocio, Med Oncol Dept, Seville, Spain

[5] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain

[6] Hosp Mar, Med Oncol Dept, Parc Salut Mar, Barcelona, Spain

[7] Hosp Badalona Germans Trias & Pujol, Med Oncol Dept, ICO Inst Catala Oncol Badalona, Barcelona, Spain

[8] Hosp Santa Creu & Sant Pau, Med Oncol Dept, Barcelona, Spain

[9] CHUVI Complejo Hosp Univ Vigo, Med Oncol, Vigo, Spain

[10] Hosp Univ Cent Asturias, Med Oncol Dept, Oviedo, Spain

[11] Hosp Univ Virgen Valme, Med Oncol Dept, Seville, Spain

[12] Hosp Univ Jaen, Med Oncol Dept, Jaen, Spain

[13] Hosp Univ Son Espases, Oncol, Palma de Mallorca, Spain

[14] Hosp Gen Univ Alicante, Med Oncol Dept, Alicante, Spain

[15] Hosp Mataro, Dept Med Oncol, Consorcio Sanitario Maresme, Barcelona, Spain

[16] Hosp San Pedro de Alcantara, Med Oncol, Caceres, Spain

[17] Roche Farma SA, Med Affairs Dept, Madrid, Spain

[18] Roche Farma SA, Clin Operat, Madrid, Spain

[19] Hosp Reg Univ Malaga Carlos Haya, Med Oncol Dept, Malaga, Spain

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.1226

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1995P

引用

页码：S1064 / S1065

页数：2

共 50 条

[11] Extensive stage small cell lung cancer (ES-SCLC) and palliative care disparities: a national cancer database study
Khullar, Karishma
Plascak, Jesse J.
Habib, Muhammad Hamza
Nagengast, Samantha
Parikh, Rahul R.
BMJ SUPPORTIVE & PALLIATIVE CARE, 2024, 14 (E3) : E2694 - E2699
[12] Atezolizumab (ATZ) plus carboplatin (Cb) and etoposide (eto) in patients with untreated extensive-stage small cell lung cancer (ES-SCLC): Results from the interim analysis of MAURIS trial
Bria, E.
Garassino, M. C.
Del Signore, E.
Morgillo, F.
Spinnato, F.
Morabito, A.
Iero, M.
Ardizzoni, A.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S1248 - S1248
[13] Identifying Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Most Likely to Benefit From Intensive Radiation Therapy
Slotman, B. J.
Faivre-Finn, C.
van Tinteren, H.
Keijser, A.
Praag, J. O.
Knegjens, J.
Hatton, M.
van Dam, I.
van der Leest, A.
Reymen, B.
Stigt, J.
Haslett, K.
Tripathi, D.
Smit, E.
Senan, S.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S153 - S154
[14] Durvalumab (D) ± tremelimumab (T) plus platinum-etoposide (EP) in first-line extensive-stage SCLC (ES-SCLC): exploratory analysis of patients with long-term clinical benefit in CASPIAN
Reinmuth, N.
Paz-Ares, L. G.
Panse, J.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 152 - 152
[15] ATEZOLIZUMAB PLUS CHEMOTHERAPY IN EXTENSIVE-STAGE SMALL-CELL LUNG CANCER
Dominguez, L.
Madronal, Carrion, I
Rodriguez, Marcos J. A.
Valera-Rubio, M.
VALUE IN HEALTH, 2023, 26 (12) : S17 - S17
[16] The role of thoracic radiotherapy (TRT) in the era of chemoimmunotherapy for extensive stage small cell lung cancer (ES-SCLC)
Turner, Cassie L.
Prasetio, Tito E.
O'Berine, Shannon
Anderson, Georgina
Hughes, Brett G. M.
Vignarajah, Dinesh
Castelli, Joanne
Lwin, Zarnie
Houston, Kathleen
Chan, Bryan A.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 167 - 167
[17] Anlotinib Combined with Etoposide as Maintenance Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Shen, B.
Wu, Y.
Shi, L.
Feng, J.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S509 - S510
[18] Financial toxicity of front-line platinum etoposide plus atezolizumab versus durvalumab in extensive-stage small-cell (ES-SCLC) lung cancer.
Harrison, Bradley
Keith, Nicole
Verbyla, Allison
Mileham, Kathryn Finch
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 23 - 23
[19] Paraneoplastic acquired haemophilia A in extensive-stage small cell lung cancer (ES-SCLC) in the era of immunotherapy
Pauls, Mehrnoosh
Rydz, Natalia
Nixon, Nancy A.
Ezeife, Doreen
BMJ CASE REPORTS, 2021, 14 (01)
[20] Phase I study of ramucirumab in combination with irinotecan plus cisplatin in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC)
Takahashi, T.
Mori, K.
Mizuno, R.
Mamesaya, N.
Kobayashi, H.
Omori, S.
Wakuda, K.
Ono, A.
Naito, T.
Murakami, H.
Kenmotsu, H.
ANNALS OF ONCOLOGY, 2021, 32 : S1165 - S1165

← 1 2 3 4 5 →